CRISPR THERAPEUTICS: REVOLUTIONIZING GENETIC MEDICINE
Why in the News ? Global Recognition: UK’s Medicines and Healthcare products Regulatory Agency approved exagamglogene autotemcel for sickle-cell disease and ß-thalassemia. Dual Approval: S. FDA also sanctioned it for sickle-cell disease, making it a pioneering CRISPR-based therapeutic approved by two major regulators. Source: Science in News About CRISPR technology: Overview: CRISPR, or Clustered Regularly …
Read More